SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-21-001784
Filing Date
2021-03-02
Accepted
2021-03-02 16:08:01
Documents
2
Period of Report
2021-02-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 10096
2 POA UPDATED AUG '20 poamdahan_updated.txt EX-24 3476
  Complete submission text file 0001562180-21-001784.txt   14930
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Issuer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AKEBIA THERAPEUTICS, INC. 245 FIRST STREET, SUITE 1100 CAMBRIDGE MA 02142
Business Address
Dahan Michel (Reporting) CIK: 0001669737 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36352 | Film No.: 21703596